JAMA Netw Open 2024 Mar 4
Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer Outcomes.
Related Questions
A patient with low-volume but high-risk prostate cancer (Gleason 8 disease) has completed a course of RT and remains on ADT with 3-month depot injecti...
New comment by Radiation Oncologist at Kansas City VA Medical Center ( September 3, 2025)
Agree with Tony, if available they should consider this test before adding additional medications.